Frequency of insulin resistance and beta cell dysfunction and their relations with clinical and biochemical features in newly-diagnosed type 2 diabetes

被引:0
|
作者
Bonora, E. [1 ]
Stoico, V. [1 ]
Negri, C. [1 ]
Trombetta, M. [1 ]
Tommasi, C. [1 ]
Grippaldi, F. [1 ]
Brangani, C. [1 ]
Pichiri, I. [1 ]
Tecilazich, F. [1 ]
Muggeo, A. [1 ]
Bonadonna, R. C. [1 ]
机构
[1] Univ Verona, I-37100 Verona, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
652
引用
收藏
页码:S263 / S263
页数:1
相关论文
共 50 条
  • [1] Relationship of chronic vascular complications with beta cell dysfunction and insulin resistance in newly-diagnosed type 2 diabetes. The VNDS Study
    Dauriz, M.
    Trombetta, M.
    Santi, L.
    Boselli, M.
    Brangani, C.
    Pichiri, I.
    Travia, D.
    Cacciatori, V.
    Negri, C.
    Stoico, V.
    Bonadonna, R. C.
    Bonora, E.
    DIABETOLOGIA, 2017, 60 : S502 - S502
  • [2] Clinical features of insulin resistance and beta cell dysfunction and the relationship to type 2 diabetes
    Stumvoll, M
    Gerich, J
    CLINICS IN LABORATORY MEDICINE, 2001, 21 (01) : 31 - +
  • [3] Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)
    Dauriz, Marco
    Trombetta, Maddalena
    Santi, Lorenza
    Boselli, Maria Linda
    Brangani, Corinna
    Pichiri, Isabella
    Travia, Daniela
    Cacciatori, Vittorio
    Negri, Carlo
    Stoico, Vincenzo
    Bonadonna, Riccardo C.
    Bonora, Enzo
    DIABETES, 2017, 66 : A429 - A429
  • [4] Insulin resistance and beta-cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10
    Bonora, Enzo
    Trombetta, Maddalena
    Dauriz, Marco
    Brangani, Corinna
    Cacciatori, Vittorio
    Negri, Carlo
    Pichiri, Isabella
    Stoico, Vincenzo
    Rinaldi, Elisabetta
    Da Prato, Giuliana
    Boselli, Maria Linda
    Santi, Lorenza
    Moschetta, Federica
    Zardini, Monica
    Bonadonna, Riccardo C.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2022, 38 (07)
  • [5] Insulin resistance and beta-cell deficiency in newly diagnosed type 2 diabetes mellitus
    Bonora, E
    Stoico, V
    Trombetta, M
    Muggeo, M
    Bonadonna, RC
    DIABETES, 2005, 54 : A325 - A325
  • [6] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Kumar, Hemant
    Mishra, Manish
    Bajpai, Surabhi
    Pokhria, Deepa
    Arya, Awadhesh Kumar
    Singh, Rakesh Kumar
    Tripathi, Kamlakar
    ACTA DIABETOLOGICA, 2013, 50 (04) : 511 - 518
  • [7] Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes
    Hemant Kumar
    Manish Mishra
    Surabhi Bajpai
    Deepa Pokhria
    Awadhesh Kumar Arya
    Rakesh Kumar Singh
    Kamlakar Tripathi
    Acta Diabetologica, 2013, 50 : 511 - 518
  • [8] Effects of diet, glibenclamide and voglibose on visceral adiposity and insulin resistance in newly-diagnosed type 2 diabetes mellitus
    Takami, K
    Takeda, N
    Sasaki, A
    Hattori, J
    Takami, R
    Yoshino, K
    Sugimoto, M
    Nakashima, K
    Okumura, S
    Koseki, S
    Matsui, M
    Hayashi, M
    Yasuda, K
    DIABETES, 1998, 47 : A92 - A92
  • [9] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Zirui Hao
    Yue Sun
    Guiping Li
    Yuli Shen
    Yingzhen Wen
    Yan Liu
    BMC Endocrine Disorders, 22
  • [10] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Hao, Zirui
    Sun, Yue
    Li, Guiping
    Shen, Yuli
    Wen, Yingzhen
    Liu, Yan
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)